← board
BMRA
distress 6/10 · elevated risk$1.57-4%today-62% from 52w high
Revenue
pre-revenue
Liquidity
$1M
Runway
0.3 yrs
Shares 1y
+10%
Price & events
-38.9% over 6M
CatalystRating changeDilutionFinancingdashed = today
-4.3%
1D
-6.0%
1W
-15.1%
1M
-28.0%
3M
-38.9%
6M
-56.4%
1Y
-40.5%
2Y
-95.0%
5Y
-96.1%
All
Overview
- Market Cap
- $4.85M
- Volume
- 1.40K
- 52 Week Range
- $1.57 – $4.14
- Total Shares
- 3.09M
- Float Shares
- 2.77M
- Short %
- 1.19%
- % Held by Insiders
- 15.24%
- % Held by Institutions
- 3.62%
- RVOL
- 0.11x
- Beta
- 0.33
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.